DrugDev Client Testimonials

Dawn Furey, (Former) Executive Director / Head of Global Operations, Merck

Dawn Furey on ways the industry can improve in the future and the transparent and honest working relationship she has experienced when working with DrugDev.

Dawn Furey, Executive Director / Head of Global Operations, Merck

 

Brenda Medina, Associate Director, Head of Analytics, BioMarin

Brenda discusses the challenges of working within a data driven industry and how DrugDev is helping to overcome some of these issues.

Brenda Medina, Associate Director, Head of Analytics, BioMarin

 

Ana Marquez, CEO, Marquez Clinical Site Partners

Ana on overcoming industry challenges and how DrugDev payments can help all sites with payment and other issues.

Ana Marquez

Tom Haag, Learning and Process Lead, Novartis

Tom Haag says he’d like to see his job disappear before going on to describe the direction he would like to see clinical trials go in over the next 5 years and compliments DrugDev on the direction we are headed.

Tom Haag

 

Chris Conklin, Director Feasibility Center of Excellence, Pfizer

Chris discusses DrugDev’s mission to make things easier for sites and the challenge of making ever more complex protocols easy to execute whilst ensuring the scientific questions are answered.Chris Conklin, Director Feasibility Center of Excellence, Pfizer

 

Joanne Wilkinson, Senior Research Coordinator, Population Health Research Institute

Joanne on how DrugDev has helped Population Health Research overcome communication challenges in large global trials and how e-consent can help trials become more efficient and global.

Screen Shot 2017-01-16 at 12.14.35